Chief Legal Officer
Javier has been practicing law for over 15 years and has spent more than 10 of those as in-house counsel in the pharmaceuticals industry.
Javier began his legal career in 2000 as a litigation associate at the law firm of Thelen Reid & Priest in New York City. In 2004, he joined the legal department at Berlex Laboratories, Inc., a subsidiary of Schering AG, which was subsequently acquired by Bayer AG in 2006. While at Berlex/Bayer, Javier served as Corporate Counsel to the clinical development function, the US diagnostic imaging business and the oncology and specialized therapeutics global business units. In 2008, Javier joined Reckitt Benckiser LLC as Senior Counsel to the healthcare category and helped successfully manage the integration of Adams Respiratory Therapeutics and its portfolio of OTC products into the core Reckitt Benckiser business. He also took on increasing responsibility for the legal affairs of RBP as the business and operations of the company grew and evolved. In 2010, he worked alongside Shaun Thaxter on the acquisition of the global (ex-US) marketing rights to the buprenorphine franchise from Merck & Co., Inc. Following the integration of the buprenorphine business and establishment of RBP as a global business, Javier was appointed VP General Counsel of RBP in 2011 with a remit to build and lead a strategically focused, high-performing team of legal and corporate compliance professionals.
Javier obtained his BS in Civil Engineering from Rutgers University and MSE in Structural Engineering from the University of Michigan. He graduated from the University of Pennsylvania with a JD and is admitted to practice law in New York, New Jersey and Virginia (corporate counsel).